292 NEOADJUVANT RADIOTHERAPY IS ASSOCIATED WITH IMPROVED PATHOLOGIC OUTCOMES AND SURVIVAL IN RESECTED STAGE II-III PANCREATIC ADENOCARCINOMA TREATED WITH MULTI-AGENT NEOADJUVANT CHEMOTHERAPY IN THE MODERN ERA

Authors :: Lee M. Ocuin
J. Eva Selfridge
Jennifer A. Dorth
David L. Bajor
Jeffrey M. Hardacre
Amr Mohamed
Joel N. Saltzman
Kavin Sugumar
John B. Ammori
Jonathan J. Hue
Luke D. Rothermel
Jordan M. Winter
Source :: Gastroenterology. 160:S-876
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Oncology
medicine.medical_specialty
Chemotherapy
Hepatology
business.industry
medicine.medical_treatment
Gastroenterology
Stage ii
medicine.disease
Radiation therapy
Internal medicine
Medicine
Adenocarcinoma
business

Tools